In an announcement made on February 26, the Centers for Disease Control and Prevention (CDC) has officially declared an end to the infant botulism outbreak linked to ByHeart formula products. Over the course of the outbreak, 48 infants suffered botulism poisoning. Thankfully, no new cases have been reported since the conclusion of 2023. Investigations and activities to comprehensively determine the root cause of the acute outbreak are still ongoing.
ByHeart, the company at the center of this incident, acted preemptively and voluntarily recalled all its infant formula products in the month of November. The outbreak first came into prominence in December 2023, raising immediate and urgent concerns amongst public health officials.
What made the rash of botulism cases even more dire was its wide geographical distribution – touching as many as 17 different states across the country. Every single case recorded during this outbreak required hospitalization for the infants involved, a testament to the seriousness of the condition they contracted. Despite the widespread nature of the outbreak and the severity of the botulism cases, there were no fatalities reported.
While the outbreak may be over, the emphasis on public health safety and prevention continues to remain high. The analysis of such incidents offers invaluable learning opportunities for infection prevention professionals in honing their skills and bettering their methodologies.
Source: https://www.aha.org/news/headline/2026-02-27-cdc-says-infant-botulism-outbreak-over